These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

888 related articles for article (PubMed ID: 27335261)

  • 41. Robust and highly efficient hiPSC generation from patient non-mobilized peripheral blood-derived CD34
    Okumura T; Horie Y; Lai CY; Lin HT; Shoda H; Natsumoto B; Fujio K; Kumaki E; Okano T; Ono S; Tanita K; Morio T; Kanegane H; Hasegawa H; Mizoguchi F; Kawahata K; Kohsaka H; Moritake H; Nunoi H; Waki H; Tamaru SI; Sasako T; Yamauchi T; Kadowaki T; Tanaka H; Kitanaka S; Nishimura K; Ohtaka M; Nakanishi M; Otsu M
    Stem Cell Res Ther; 2019 Jun; 10(1):185. PubMed ID: 31234949
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nuclear reprogramming with a non-integrating human RNA virus.
    Driscoll CB; Tonne JM; El Khatib M; Cattaneo R; Ikeda Y; Devaux P
    Stem Cell Res Ther; 2015 Mar; 6(1):48. PubMed ID: 25889591
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Generation and Characterization of Patient-Specific Induced Pluripotent Stem Cell for Disease Modeling.
    Sivapatham R; Zeng X
    Methods Mol Biol; 2016; 1353():25-44. PubMed ID: 25520284
    [TBL] [Abstract][Full Text] [Related]  

  • 44. OCT4 and SOX2 Work as Transcriptional Activators in Reprogramming Human Fibroblasts.
    Narayan S; Bryant G; Shah S; Berrozpe G; Ptashne M
    Cell Rep; 2017 Aug; 20(7):1585-1596. PubMed ID: 28813671
    [TBL] [Abstract][Full Text] [Related]  

  • 45. An Overview of Direct Somatic Reprogramming: The Ins and Outs of iPSCs.
    Menon S; Shailendra S; Renda A; Longaker M; Quarto N
    Int J Mol Sci; 2016 Jan; 17(1):. PubMed ID: 26805822
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Generation of iPSCs from mouse fibroblasts with a single gene, Oct4, and small molecules.
    Li Y; Zhang Q; Yin X; Yang W; Du Y; Hou P; Ge J; Liu C; Zhang W; Zhang X; Wu Y; Li H; Liu K; Wu C; Song Z; Zhao Y; Shi Y; Deng H
    Cell Res; 2011 Jan; 21(1):196-204. PubMed ID: 20956998
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Human-induced pluripotent stem cells produced under xeno-free conditions.
    Ross PJ; Suhr ST; Rodriguez RM; Chang EA; Wang K; Siripattarapravat K; Ko T; Cibelli JB
    Stem Cells Dev; 2010 Aug; 19(8):1221-9. PubMed ID: 20030562
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Generation of Human iPSCs by Protein Reprogramming and Stimulation of TLR3 Signaling.
    Liu C; Ameen M; Himmati S; Thomas D; Sayed N
    Methods Mol Biol; 2021; 2239():153-162. PubMed ID: 33226618
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Rapid and Efficient Generation of Transgene-Free iPSC from a Small Volume of Cryopreserved Blood.
    Zhou H; Martinez H; Sun B; Li A; Zimmer M; Katsanis N; Davis EE; Kurtzberg J; Lipnick S; Noggle S; Rao M; Chang S
    Stem Cell Rev Rep; 2015 Aug; 11(4):652-65. PubMed ID: 25951995
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Partial inhibition of differentiation associated with elevated protein levels of pluripotency factors in mouse embryonic stem cells expressing exogenous EGAM1N homeoprotein.
    Sato S; Nakazawa M; Kihara Y; Kubo Y; Sato Y; Kikuchi T; Nonaka A; Sasaki A; Iwashita J; Murata J; Hosaka M; Kobayashi M
    J Biosci Bioeng; 2015 Nov; 120(5):562-9. PubMed ID: 25817697
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Two-phase analysis of molecular pathways underlying induced pluripotent stem cell induction.
    Lin Z; Perez P; Lei D; Xu J; Gao X; Bao J
    Stem Cells; 2011 Dec; 29(12):1963-74. PubMed ID: 21956995
    [TBL] [Abstract][Full Text] [Related]  

  • 52. An improved reprogrammable mouse model harbouring the reverse tetracycline-controlled transcriptional transactivator 3.
    Alaei S; Knaupp AS; Lim SM; Chen J; Holmes ML; Änkö ML; Nefzger CM; Polo JM
    Stem Cell Res; 2016 Jul; 17(1):49-53. PubMed ID: 27558603
    [TBL] [Abstract][Full Text] [Related]  

  • 53. MicroRNA-302 increases reprogramming efficiency via repression of NR2F2.
    Hu S; Wilson KD; Ghosh Z; Han L; Wang Y; Lan F; Ransohoff KJ; Burridge P; Wu JC
    Stem Cells; 2013 Feb; 31(2):259-68. PubMed ID: 23136034
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Generation of an integration-free induced pluripotent stem cell line (CSC-43) from a patient with sporadic Parkinson's disease.
    Marote A; Pomeshchik Y; Goldwurm S; Collin A; Lamas NJ; Pinto L; Salgado AJ; Roybon L
    Stem Cell Res; 2018 Mar; 27():82-85. PubMed ID: 29334630
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Transcriptome Signature and Regulation in Human Somatic Cell Reprogramming.
    Tanaka Y; Hysolli E; Su J; Xiang Y; Kim KY; Zhong M; Li Y; Heydari K; Euskirchen G; Snyder MP; Pan X; Weissman SM; Park IH
    Stem Cell Reports; 2015 Jun; 4(6):1125-39. PubMed ID: 26004630
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mechanisms of iPS cell generation and beyond.
    Kaji K
    Keio J Med; 2017; 66(1):14. PubMed ID: 28356547
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Reprogramming of human somatic cells to pluripotency with defined factors.
    Park IH; Zhao R; West JA; Yabuuchi A; Huo H; Ince TA; Lerou PH; Lensch MW; Daley GQ
    Nature; 2008 Jan; 451(7175):141-6. PubMed ID: 18157115
    [TBL] [Abstract][Full Text] [Related]  

  • 58. More synergetic cooperation of Yamanaka factors in induced pluripotent stem cells than in embryonic stem cells.
    Huang J; Chen T; Liu X; Jiang J; Li J; Li D; Liu XS; Li W; Kang J; Pei G
    Cell Res; 2009 Oct; 19(10):1127-38. PubMed ID: 19736564
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Successful Derivation of an Induced Pluripotent Stem Cell Line from a Genetically Nonpermissive Enhanced Green Fluorescent Protein-Transgenic FVB/N Mouse Strain.
    Abbey D; Singh G; Verma I; Derebail S; Kolkundkar U; Chandrashekar DS; Acharya KK; Vemuri MC; Seshagiri PB
    Cell Reprogram; 2019 Oct; 21(5):270-284. PubMed ID: 31596624
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Transcriptional Reactivation of OTX2, RX1 and SIX3 during Reprogramming Contributes to the Generation of RPE Cells from Human iPSCs.
    Li P; Sun X; Ma Z; Liu Y; Jin Y; Ge R; Hao L; Ma Y; Han S; Sun H; Zhang M; Li R; Li T; Shen L
    Int J Biol Sci; 2016; 12(5):505-17. PubMed ID: 27019633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 45.